McKinley Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

McKinley Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-129,350	Closed	-$1.42M	–	625
2017 Q1	$1.42M	Buy	129,350 +72	+0.1%	+$836	0.05%	211
2016 Q4	$1.75M	Sell	129,278 -103,519	-44%	-$1.44M	0.07%	189
2016 Q3	$2.87M	Buy	232,797 +41	+0%	+$483	0.1%	169
2016 Q2	$2.55M	Sell	232,756 -68	-0%	-$761	0.12%	169
2016 Q1	$2.54M	Buy	232,824 +138,829	+148%	+$1.75M	0.12%	160
2015 Q4	$1.63M	Buy	93,995 +64	+0.1%	+$1.15K	0.08%	192
2015 Q3	$1.87M	Sell	93,931 -86,800	-48%	-$1.99M	0.09%	185
2015 Q2	$2.97M	Sell	180,731 -293	-0.2%	-$5.08K	0.13%	175
2015 Q1	$2.82M	Buy	+181,024	New	+$2.81M	0.11%	178

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

McKinley Capital Management's SCMP Position: Q2 2017 in Review

McKinley Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2017, closing a stake of 129,350 shares — an estimated $1.42M sold.

McKinley Capital Management first reported a position in SCMP in Q1 2015 and held it in 9 quarters. The position peaked at $2.97M in Q2 2015. 167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.

McKinley Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
McKinley Capital Management sold 129,350 Sucampo Pharmaceuticals, Inc. shares in Q2 2017, an estimated $1.42M.
McKinley Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 9 quarters.
McKinley Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $2.97M in Q2 2015.
167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2017.

Based on McKinley Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.